Starpharma Holdings Ltd banner

Wall St Price Targets

PQ6 Price Forecast
Based on 3 analysts

+179% Upside
from €0.288 today

Starpharma Holdings Ltd (PQ6)’s 12-month stock price forecast through October 2027 has a consensus target of €0.804, implying 179% upside. The forecast is based on price targets from 3 Wall Street analysts.

PQ6 Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for PQ6 yet.

Starpharma Holdings Ltd Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PQ6's stock price target?
Price Target
0.804 EUR

According to Wall Street analysts, the average 1-year price target for PQ6 is 0.804 EUR with a low forecast of 0.796 EUR and a high forecast of 0.827 EUR.

What is the Revenue forecast for Starpharma Holdings Ltd?
Projected CAGR
68%

Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 68%.

What is the Gross Profit forecast for Starpharma Holdings Ltd?
Projected CAGR
12%

The compound annual growth rate for Gross Profit over the next 2 years is 12%.

Back to Top